New stock news | Dizzer Medicine (688192.SH) Hong Kong IPO prospectus failed

Zhtng Cijng APP learned that the Hong Kong stock prospectus submitted by Dezhe (Jiangsu) Pharmaceutical Co., Ltd. (referred to as Dezhe Pharmaceutical (688192.SH)) on January 23, 2026, was valid for 6 months and expired on July 23, 2026. At the time of submission, Goldman Sachs and Huatai International were its joint sponsors.